BioNova
Germantown
About BioNova
BioNova has acquired a technology from the University of Memphis that involves a spongy material from the outer shells of lobster and shrimp. This material has a natural antibiotic effect and may have an additional antibiotic influence if soaked in antibiotics. BioNova has developed this process to treat post-surgical wounds.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $2.9M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2021)
- Website: bionovamedical.com
- Phone: (901) 748-2581
Industries & Categories
Health Care, Medical
Canonical: https://fsome.com/organization/bionova-43658 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.